Xianda Lin1,2, Yungang Cao1, Jueyue Yan1, Zheng Zhang3, Zusen Ye3, Xiaoyan Huang1, Zicheng Cheng1, Zhao Han1. 1. Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. 2. Department of Neurology, The Wenzhou Third Clinical Institute Affiliated To Wenzhou Medical University. 3. Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University.
Abstract
AIM: Intracerebral hemorrhage (ICH) is one of the most severe complications of thrombolysis. Symptomatic ICHs are associated with adverse outcomes. It has been reported that symptomatic ICHs most commonly occur within the first few hours after the initiation of intravenous thrombolysis. Our aim here was to determine the risk factors for early ICH (within 12 h) after thrombolysis. METHODS: We analyzed patients with acute ischemic stroke who received intravenous alteplase at two hospitals affiliated to Wenzhou Medical University between March 2008 and November 2017. The ICH diagnosis time was defined as the time from the intravenous administration of alteplase to the first detection of hemorrhage on computed tomography. Demographic data, medical history, clinical features, and laboratory examination results were collected. Univariate analysis followed by multivariable logistic regression analysis was performed to determine the predictors of early ICH (within 12 h) after thrombolysis. RESULTS: Among 197 patients, early ICH (within 12 h) after thrombolysis occurred in 13 patients (6.6%). In the univariate analysis, patients with early ICHs were significantly correlated with prior stroke (P=0.04). After adjusting for potential confounders in the multivariate analysis, prior stroke (odds ratio [OR]: 5.752, 95% confidence interval [CI]: 1.487-22.248; P=0.011) and atrial fibrillation (OR: 5.428, 95% CI: 1.427-20.640; P=0.013) were associated with early ICH. CONCLUSIONS: Prior stroke and atrial fibrillation are independent risk factors for early ICHs (within 12 h) after intravenous thrombolysis with alteplase.
AIM: Intracerebral hemorrhage (ICH) is one of the most severe complications of thrombolysis. Symptomatic ICHs are associated with adverse outcomes. It has been reported that symptomatic ICHs most commonly occur within the first few hours after the initiation of intravenous thrombolysis. Our aim here was to determine the risk factors for early ICH (within 12 h) after thrombolysis. METHODS: We analyzed patients with acute ischemic stroke who received intravenous alteplase at two hospitals affiliated to Wenzhou Medical University between March 2008 and November 2017. The ICH diagnosis time was defined as the time from the intravenous administration of alteplase to the first detection of hemorrhage on computed tomography. Demographic data, medical history, clinical features, and laboratory examination results were collected. Univariate analysis followed by multivariable logistic regression analysis was performed to determine the predictors of early ICH (within 12 h) after thrombolysis. RESULTS: Among 197 patients, early ICH (within 12 h) after thrombolysis occurred in 13 patients (6.6%). In the univariate analysis, patients with early ICHs were significantly correlated with prior stroke (P=0.04). After adjusting for potential confounders in the multivariate analysis, prior stroke (odds ratio [OR]: 5.752, 95% confidence interval [CI]: 1.487-22.248; P=0.011) and atrial fibrillation (OR: 5.428, 95% CI: 1.427-20.640; P=0.013) were associated with early ICH. CONCLUSIONS:Prior stroke and atrial fibrillation are independent risk factors for early ICHs (within 12 h) after intravenous thrombolysis with alteplase.
Entities:
Keywords:
Acute ischemic stroke; Early intracerebral hemorrhage; Intravenous thrombolysis
Authors: William N Whiteley; Karsten Bruins Slot; Peter Fernandes; Peter Sandercock; Joanna Wardlaw Journal: Stroke Date: 2012-09-20 Impact factor: 7.914
Authors: D Strbian; T Sairanen; A Meretoja; J Pitkäniemi; J Putaala; O Salonen; H Silvennoinen; M Kaste; T Tatlisumak Journal: Neurology Date: 2011-06-29 Impact factor: 9.910
Authors: Christoph Gumbinger; Philipp Gruschka; Markus Böttinger; Kristin Heerlein; Robin Barrows; Werner Hacke; Peter Ringleb Journal: Stroke Date: 2011-10-13 Impact factor: 7.914
Authors: Shadi Yaghi; Amelia K Boehme; Jamil Dibu; Christopher R Leon Guerrero; Syed Ali; Sheryl Martin-Schild; Kara A Sands; Ali Reza Noorian; Christina A Blum; Shuchi Chaudhary; Lee H Schwamm; David S Liebeskind; Randolph S Marshall; Joshua Z Willey Journal: JAMA Neurol Date: 2015-12 Impact factor: 18.302